D-0310-2025 Class II

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0310-2025 was initiated by Zydus Pharmaceuticals (USA) Inc on Mar 21, 2025 and is designated Class II. Reason for recall: Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet. Affected quantity: 13,128 100-Count Bottles.

Recall details

Product Type
Drugs
Report Date
Apr 16, 2025
Initiation Date
Mar 21, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,128 100-Count Bottles

Product description

Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.

Reason for recall

Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

Distribution pattern

US Nationwide.

Code information

Lot #: M314265, Exp.: 31 October 2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0310-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0310-2025. Report a data issue: hello@regdatalab.com.